—
mcg/day
112
mcg/day
0
mcg
—
mcg/week
—
mcg/day
112
mcg/day
0
mcg
—
mcg/week
The Thyroid Dosing Calculator is a clinical tool designed to assist healthcare providers in determining the appropriate dose of levothyroxine (LT4) for patients with hypothyroidism. Levothyroxine is the standard treatment for hypothyroidism, a condition affecting approximately 5% of the general population and up to 10% of women over age 60. Proper dosing is critical because both underdosing and overdosing carry significant health risks.
Hypothyroidism occurs when the thyroid gland fails to produce sufficient thyroid hormones (T4 and T3). The most common cause worldwide is iodine deficiency, while in iodine-sufficient countries, Hashimoto's thyroiditis (autoimmune thyroiditis) is the leading cause. Other causes include surgical thyroidectomy, radioactive iodine ablation, external radiation therapy, and certain medications such as amiodarone and lithium.
The standard approach to levothyroxine dosing uses a weight-based calculation. For complete thyroid hormone replacement in patients with no residual thyroid function, the typical dose is 1.6 mcg/kg/day. Patients who have undergone partial thyroidectomy typically require 1.0 mcg/kg/day, while patients requiring TSH suppression for differentiated thyroid cancer may need 2.0-2.5 mcg/kg/day depending on risk stratification.
This calculator provides initial dosing estimates based on body weight and thyroid status, as well as dose adjustment recommendations for patients already on levothyroxine therapy. When the current TSH is above the target, the calculator suggests a dose increase of approximately 12.5%. Conversely, if TSH is well below target (less than half the target value), a dose reduction of 12.5% is suggested. These incremental adjustments align with the American Thyroid Association (ATA) guidelines, which recommend changes of 12.5-25 mcg at a time.
Important clinical considerations include: elderly patients and those with coronary artery disease should start at lower doses (25-50 mcg/day) with gradual titration; absorption is affected by timing (take on empty stomach, 30-60 minutes before breakfast); certain medications (calcium, iron, proton pump inhibitors) interfere with absorption and should be separated by 4 hours; and TSH should be rechecked 6-8 weeks after any dose change to allow achievement of steady state. Pregnancy increases levothyroxine requirements by approximately 30-50%, and dose should be adjusted promptly upon confirmation of pregnancy.
The calculator uses the following approaches:
Initial Dose (No Current Therapy):
Dose Adjustment (Already on Therapy):
The weekly total dose is also displayed to facilitate alternate-day dosing strategies when precise daily doses fall between available tablet strengths.
The Recommended Starting Dose represents the calculated daily levothyroxine dose. For new patients, this is based on weight and thyroid status. For existing patients, it incorporates the adjustment. The Weight-Based Full Replacement shows what a complete replacement dose would be at 1.6 mcg/kg. The Dose Adjustment indicates the increment or decrement from the current dose. Round to the nearest available tablet strength (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 mcg). Always recheck TSH in 6-8 weeks after any change. Clinical correlation is essential.
Inputs
Results
Full replacement at 1.6 mcg/kg = 112 mcg/day. Start at 50-100 mcg if elderly or cardiac risk; otherwise start at full dose.
Inputs
Results
TSH 6.5 is above target of 2. Increase by 12.5% (12.5 mcg) from 100 to ~112 mcg. Recheck TSH in 6-8 weeks.
Levothyroxine (LT4) is a synthetic form of thyroxine (T4), the primary hormone produced by the thyroid gland. It is the standard of care for hypothyroidism treatment. Brand names include Synthroid, Levoxyl, Tirosint, and Unithroid. It has a long half-life of 6-7 days, allowing once-daily dosing.
Take levothyroxine on an empty stomach, preferably 30-60 minutes before breakfast or at bedtime (at least 3 hours after the last meal). Consistency in timing is more important than the specific time. Avoid taking with calcium, iron, antacids, or coffee, which impair absorption.
Most patients notice improvement in energy and symptoms within 2-3 weeks, though full effect takes 4-6 weeks. TSH levels take 6-8 weeks to reach steady state after a dose change. Some symptoms like weight, hair, and skin changes may take 3-6 months to fully resolve.
The reference range for TSH is typically 0.4-4.0 mIU/L, though this varies by laboratory. Many endocrinologists target 1-2.5 mIU/L for optimal symptom control. For thyroid cancer patients on suppression therapy, the target may be below 0.5 or even below 0.1 mIU/L depending on risk.
Common reasons include: non-adherence, taking medication with food or interfering supplements (calcium, iron), concurrent medications (PPIs, estrogen, carbamazepine), malabsorption conditions (celiac disease, gastric bypass), inadequate dose, or switching between brands with different bioavailability.
Yes, overtreatment (suppressed TSH) increases risk of atrial fibrillation (3x risk), accelerated bone loss (especially postmenopausal women), anxiety, insomnia, tremors, and heat intolerance. Long-term TSH suppression below 0.1 is only justified for high-risk thyroid cancer patients.
Thyroid hormone requirements are primarily determined by lean body mass. The standard 1.6 mcg/kg uses total body weight as an approximation. Obese patients may need doses closer to 1.0-1.2 mcg/kg of actual body weight since adipose tissue has lower metabolic demands for thyroid hormone.
Yes, levothyroxine requirements increase by 30-50% during pregnancy, often as early as the 4th-6th week. The ATA recommends hypothyroid women increase their dose by 2 extra tablets per week as soon as pregnancy is confirmed and check TSH every 4 weeks during the first half of pregnancy.
Some patients feel better on combination T4/T3 therapy, though large trials show no consistent superiority over T4 alone. The ATA does not routinely recommend combination therapy but acknowledges it as a trial option for persistent symptoms. T3 should not exceed 5-15 mcg/day in divided doses.
After starting or changing dose: recheck TSH in 6-8 weeks. Once stable: check TSH every 6-12 months. More frequent monitoring during pregnancy, after weight changes >10%, when starting interacting medications, or in elderly patients. Free T4 should be checked if TSH is discordant with symptoms.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
Free Testosterone Calculator
Thyroid & Hormone Calculators
Testosterone/Estradiol Ratio
Thyroid & Hormone Calculators
SHBG Calculator
Thyroid & Hormone Calculators
Cortisol Suppression Test Calculator
Thyroid & Hormone Calculators
Calcium Infusion Calculator
Thyroid & Hormone Calculators
FRAX Score (Fracture Risk)
Thyroid & Hormone Calculators
